Table 2 Dimensions of knowledge translation (knowledge gain; behavior modification)
Quantitative parameters | Qualitative parameters (following a structured interview guideline) |
|---|---|
number of participants, response of questionnaires, use of training measures | • questions regarding user behavior • identification of barriers |
knowledge gain measured by two questionnaires (pre- and post test) | • subjective evaluation of knowledge gain |
"behavior modification screening" gathered by EBM2000plus (GOÄ): |  |
• (03313 orientation survey of psychopathological status) • 03314 (857) mental tests • 03341 GP-geriatric basic assessment investigation at t2: assessment of 4 quarters before and 2 quarters after intervention | • self-evaluation of behavior • identification of barriers |
„behavior modification diagnosis/differential diagnosis" assessed via six figures of ICD-10-GM 2005: F00, F01, F02, F03, F07, G32, R54 data gathered at t2: assessment of 4 quarters before and 2 quarters after intervention | • question whether diagnostic behavior has changed • identification of barriers |
„behavior modification therapy" ascertained via prescriptions of anti-dementives*: |  |
• cholinesterase inhibitors • memantine • ginkgo biloba compounds • piracetam investigation at t2: assessment of 4 quarters before and 2 quarters after intervention | • identify whether there is an increase in the prescription of evaluated anti-dementives (e.g. cholinesterase inhibitors, memantines) and whether there is a decrease in the prescription of untested or unreliable anti-dementives (e.g. ginkgo biloba compounds, piracetam) • question regarding future drug therapy • identification of barriers |
„behavior modification treatment" gathered by EBM2000plus: 03001 coordination of GP-related care 03002 coordination of GP-related care in nursing homes 21230 continuous co-care in the domestic environment 21231 continuous co-care in a nursing facility 21232 psychiatric treatment investigation at t2: assessment of 4 quarters before and 2 quarters after intervention | • question regarding prescription of non drug-related therapy • question regarding support groups for family members • interaction with patients and family members when patient is suspected to suffer from dementia and when the diagnosis has been confirmed • identification of barriers |